Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00503) | |||||
---|---|---|---|---|---|
Name |
Oxymorphone
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
oxymorphone; Numorphan; Oximorphonum; 76-41-5; Dihydrohydroxymorphinone; 14-Hydroxydihydromorphinone; Dihydroxymorphinone; Oxymorphine; 7,8-Dihydro-14-hydroxymorphinone; (14S)-14-Hydroxydihydromorphinone; Dihydro-14-hydroxymorphinone; Numorphone; Morphinone, dihydro-14-hydroxy-; UNII-9VXA968E0C; CHEMBL963; 9VXA968E0C; CHEBI:7865; NIH10323; NSC-19045; 3,14-Dihydroxy-4,5-alpha-epoxy-17-methylmorphinan-6-one; Ossimorfone; Oximorfona; Oxymorphonum; Morphinan-6-one, 3,14-dihydroxy-4,5-alpha-epoxy-17-methyl-; Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-methyl- (8CI); NSC 19045; (-)-Oxymorphone; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one; Ossimorfone [DCIT]; Oxymorphone [INN:BAN]; Oximorfona [INN-Spanish]; Oxymorphonum [INN-Latin]; Oxymorphone cii; HSDB 8060; EINECS 200-959-7; Oxymorphone (INN); EN3202; BRN 0041588; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)-; SCHEMBL3571; GTPL7094; IDS-NO-003; DEA No. 9652; DTXSID5023409; (5alpha)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-one; HY-B0618; NSC19045; Oxymorphone 0.1 mg/ml in Methanol; Oxymorphone 1.0 mg/ml in Methanol; ZINC3875483; BDBM50001707; NIH 10323; AKOS015962232; DB01192; Oxycodone hydrochloride impurity, oxymorphone-; C08019; D08323; Q423380; 4,5-Epoxy-3,14-dihydroxy-N-methyl-6-oxomorphinan; Morphinone, 7,8-dihydro-14-hydroxy- (6CI,7CI); 4,5alpha-Epoxy-3,14-dihydroxy-17-methyl morphinan-6-one; Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-methyl-; (5alpha)-4,5-Epoxy-3,14-dihydroxyl-17-methylmorphinan-6-one; Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-methyl-, (5.alpha.)-; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)- (9CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5-alpha)- (9CI); Oxymorphone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; (1S,5R,13R,17S)-10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one; 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(oxymorphone); 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(xymorphone); 10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-14-one
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Anaesthesia | ICD-11: 8E22 | [1] | ||
PubChem CID | |||||
Formula |
C17H19NO4
|
||||
Canonical SMILES |
CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
|
||||
InChI |
1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1
|
||||
InChIKey |
UQCNKQCJZOAFTQ-ISWURRPUSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5284604"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 301.34 | Topological Polar Surface Area | 70 | |
XlogP | 0.8 | Complexity | 539 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Oxymorphone 20 mg tablet | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 1; Fd&c yellow no. 6; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 1; Fd&c yellow no. 6; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | St Marys Medical Park Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 1; Fd&c yellow no. 6; Titanium dioxide; Triacetin; Polysorbate 80; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 1; Fd&c yellow no. 6; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Alpha.-tocopherol; Fd&c blue no. 1; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Alpha-tocopherol; Fd&c blue no. 1; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Aluminum oxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 40 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c yellow no. 6; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [8] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Sodium stearyl fumarate; Fd&c yellow no. 6; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c yellow no. 6; Titanium dioxide; Triacetin; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Alpha.-tocopherol; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Aluminum oxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Alpha-tocopherol; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 12 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium stearyl fumarate; Fd&c yellow no. 6; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [8] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium stearyl fumarate; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [8] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c red no. 27; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
D&C red no. 27 | DIG Info | Solute carrier SLCO2B1 (Ki = 1 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Sodium stearyl fumarate; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [4] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | CorePharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 2; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aurolife Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 2; Magnesium stearate; Aluminum oxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 2; Magnesium stearate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack; Endo Pharmaceuticals; KVK Tech; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Par Pharmaceutical; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-tocopherol; Citric acid monohydrate; Ferric oxide red; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Silicon dioxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 15 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium stearyl fumarate; Fd&c yellow no. 6; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [8] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium stearyl fumarate; Fd&c yellow no. 6; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [8] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Fd&c yellow no. 6; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium stearyl fumarate; Fd&c yellow no. 6; Titanium dioxide; Triacetin; Polysorbate 80; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Fd&c yellow no. 6; Magnesium stearate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Magnesium stearate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | CorePharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-tocopherol; Fd&c yellow no. 6; Citric acid monohydrate; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aurolife Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [4] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c red no. 27; Magnesium stearate; Aluminum oxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
D&C red no. 27 | DIG Info | Solute carrier SLCO2B1 (Ki = 1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c red no. 30; Magnesium stearate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | American Health Packaging; Endo Pharmaceuticals; KVK Tech; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Par Pharmaceutical; Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [10] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Silicon dioxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 30 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Fd&c blue no. 1; Fd&c yellow no. 6; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Citric acid monohydrate; Ferric oxide red; Talc; Titanium dioxide; Polyvinyl alcohol; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-tocopherol; Citric acid monohydrate; Ferric oxide red; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Silicon dioxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 7.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [4] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-tocopherol; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferrosoferric oxide; Talc; Titanium dioxide; Silicon dioxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Oxymorphone 15 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium stearyl fumarate; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [5] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha-tocopherol; Citric acid monohydrate; Talc; Titanium dioxide; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Endo Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [9] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Hypromellose 2208 (100000 mpa.s); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Mallinckrodt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Actavis Pharma; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Polyvinyl alcohol, unspecified; Xanthan gum
|
|||||
Dosage Form | 12 HR Extended Release Oral Tablet | |||||
Company | Impax Generics; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.